These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17417931)

  • 21. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
    Levy P
    Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.
    Palmer JL; Gibbs M; Scheijbeler HW; Kotchie RW; Nielsen S; White J; Valentine WJ
    Adv Ther; 2008 Aug; 25(8):752-74. PubMed ID: 18704282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global burden of diabetes and its complications: an emerging pandemic.
    van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study.
    von Ferber L; Köster I; Hauner H
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):97-104. PubMed ID: 17318768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognizing the rising impact of diabetes in seniors and implications for its management.
    Drab SR
    Consult Pharm; 2009 Jun; 24 Suppl B():5-10. PubMed ID: 19555130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is public health practice telling us about diabetes?
    Albright A
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S12-8. PubMed ID: 18358248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes in the 1990s--an overview.
    Jiwa F
    Stat Bull Metrop Insur Co; 1997; 78(1):2-8. PubMed ID: 9029704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.
    Levin P
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():66-75. PubMed ID: 18577158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and patterns of care of newly diagnosed type 2 diabetic patients.
    Di Pietro S; Comaschi M; Coscelli C; Cucinotta D; Giorda C; Noacco C; Vespasiani G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):e31-3. PubMed ID: 17590320
    [No Abstract]   [Full Text] [Related]  

  • 35. Provider organization performance assessment utilizing diabetes physician recognition program.
    Wall B; Chiao E; Plauschinat CA; Miner PA; Jackson JH; Humphrey B
    Am J Manag Care; 2009 Feb; 15(2):132-6. PubMed ID: 19284810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment satisfaction of diabetic patients: what are the contributing factors?
    Biderman A; Noff E; Harris SB; Friedman N; Levy A
    Fam Pract; 2009 Apr; 26(2):102-8. PubMed ID: 19254969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes in pregnancy: a wolf in sheep's clothing.
    Cheung NW; McElduff A; Ross GP
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):479-83. PubMed ID: 16401211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
    Colagiuri S; Walker AE
    Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
    Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
    Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care costs associated with treatment modification in type 2 diabetes mellitus patients taking oral anti-diabetic drugs.
    Nrishnarajah G; Bhosle M; Chapman R
    Manag Care; 2011 Jun; 20(6):42-8. PubMed ID: 21739924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.